Recent News

• 11.04.2026 - IM Cannabis Raises US$1,200,000 of Gross Proceeds in Convertible Note Financing
• 09.29.2026 - IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
• 09.24.2026 - IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
• 09.23.2026 - IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 09.23.2026 - IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
• 09.23.2026 - IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market
• 09.02.2026 - IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
• 08.27.2026 - IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
• 08.18.2026 - IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
• 08.17.2026 - IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets

Recent Filings

• 11.04.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.04.2026 - EX-99.1 EX-99.1
• 10.20.2026 - EFFECT Notice of Effectiveness
• 10.08.2026 - F-3 Registration statement by foreign private issuers
• 10.02.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.02.2026 - EX-99.1 EX-99.1
• 09.30.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.30.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.30.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.28.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]